Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancer.
| Autor: | VAROL, UMUT1 varolumut@yahoo.com, OKTAY, ESIN2, YILDIRIM, MUSTAFA3, ZEKI GOKHAN SURMELI1, DIRICAN, AHMET4, MEYDAN, NEZIH2, KARACA, BURCAK1, KARABULUT, BULENT1, USLU, RUCHAN1 |
|---|---|
| Zdroj: | Molecular & Clinical Oncology. 2014, Vol. 2 Issue 1, p166-170. 5p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|